Filing Details
- Accession Number:
- 0001209191-10-042322
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-12 13:00:00
- Reporting Period:
- 2010-08-12
- Filing Date:
- 2010-08-12
- Accepted Time:
- 2010-08-12 16:01:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1336015 | Christopher Mengler | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | President, Global Pharm. Div. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-08-12 | 2,000 | $15.19 | 59,706 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
